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Use of Subcutaneous Fluids in Paediatric Palliative Care: A Case Study 
Abstract 
Quality of life is a major consideration in paediatric palliative care, particularly at the 
end of life.  Symptom management contributes to this, the ultimate objective being 
the child’s comfort. Hydration is often a part of symptom management but can be 
difficult and contentious.  This article presents a case study outlining the 
administration of subcutaneous fluids in the hospice environment. It discusses 
subcutaneous fluids generally, their use in paediatric palliative care, the range of 
factors requiring careful consideration and the case study of child and family 
outcomes.  
Introduction 
Quality of life is a major consideration throughout a child’s palliative care journey, 
none more so than the final days of life (Together for Short Lives 2018). Symptom 
management is an important component of this and encompasses a wide variety of 
physical and psychological symptoms. The ultimate aim of symptom management is 
to ensure that the child is as comfortable as possible (Together for Short Lives 
2016). When considering symptom control, careful thought must be given to how a 
child is hydrated. Hydration must be carefully planned and implemented, as there is 
a risk of unwanted symptoms such as fluid retention, including peripheral oedema, 
increased respiratory secretions and pleural effusion (Keeler 2010).  
In the paediatric palliative care setting discussions take place to determine parental 
wishes for end of life care.  These discussions include the type of treatment that 
parents would like to be considered and the preferred place of death (Hoell et al 
2018). The place of death can be significant to a parent, and facilitating their wishes 
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is seen by palliative care staff as an important part of the care pathway (Basu and 
Swil 2018). The National Institute for Health and Care Excellence Guideline for 
Managing Hydration and Nutrition in End of Life Care for Infants, Children and Young 
People (NICE 2016) states that staff should be aware of the significant effect on care 
that enteral tube and intravenous fluids may have. Where, due to their condition, a 
child cannot receive fluids orally or via enteral tubes, the options are quite often 
limited to intravenous therapy. Many children’s hospices do not provide intravenous 
therapy, so the child would need to be transferred to an inpatient hospital 
environment.  This could be in conflict with the expressed wishes of the family.  This 
article discusses a decision to administer subcutaneous fluids to Rosie (pseudonym) 
at end of life, and describes how this was achieved in the children’s hospice setting.  
 
Rosie 
Rosie was a child recently admitted to the hospice for end of life care.  Her parents 
had expressed their wish for Rosie to receive hospice based end of life care in her 
advance care plan.  As is often the case in paediatric palliative care the duration of 
the end of life stage was uncertain (NICE 2016) and this influenced discussions 
about Rosie’s care.  Rosie had long term dysphagia associated with her primary 
condition, and as such, would not tolerate oral fluids. In days prior to admission to 
the hospice, Rosie had become acutely unwell, with a severe, life threatening 
gastrointestinal condition.   Along with the risk of dehydration, Rosie had been noted 
to be experiencing increased episodes of myoclonus (involuntary muscle 
contractions). Dehydration was a likely principle cause of the increased symptoms. 
Rosie was unable to receive enteral fluids due to her condition so intravenous fluids 
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would normally be indicated.  However, since the hospice does not currently have 
facilities to provide intravenous fluids, this would have necessitated a return to 
hospital, conflicting with her parents’ wishes.  This led to discussions between 
medical and nursing colleagues about how hydration could be managed. 
Administration of subcutaneous fluids was considered as a therapeutic trial. 
Discussion with family included exploration of definable outcomes of receiving the 
fluids, including possible improvements in symptom control.  
Prior to the infusion being commenced, hyaluronidase was used to facilitate the 
diffusion of the fluids being delivered. Hyaluronidases are enzymes which breakdown 
hyaluronic acid, an essential part of the extracellular matrix. Therefore they increase 
tissue permeability and facilitate the absorption of subcutaneous fluids (Weber et al 
2019). This was administered through the subcutaneous catheter, immediately prior 
to the infusion being commenced. The fluids were continued for 48 hours, and from 
observations recorded, Rosie’s myoclonus symptoms had improved following the 
first 12 hours of the infusion. The infusion site was showing signs of infection after 72 
hours, including erythema and warmth to the site. The infusion was discontinued, as 
it was apparent that Rosie was in the final hours of her life. Rosie died at the 




Indications for use of subcutaneous fluids include dysphagia, hypercalcaemia, 
nausea and vomiting, myoclonus and assisting sedation. Subcutaneous fluids are 
administered regularly in the adult palliative care setting, and their use is well 
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documented (Good et al 2014). Although the subcutaneous route is commonly used 
for symptom control in paediatric palliative care (Together for Short Lives 2016), 
there is a dearth of literature to underpin the administration of subcutaneous infusion 
of fluids in this field.  However, there are studies relating to rehydration in acute 
settings (Kuensting 2011, Marikar et al 2014).  In order to facilitate the use of 
subcutaneous fluids in a children’s hospice environment, the guidance for acute 
paediatric settings  (Horeczko 2016) was adapted, applying the principles of 
hydration rather than rehydration.   
The subcutaneous tissue, also referred to as the hypodermis is the deepest layer of 
skin. It consists of elastic fibres, lymphatic vessels, loose connective tissue, and 
adipose tissue (Draelos and Pugliese 2011). Functions of this layer include support 
and cushioning from external force and recirculation of extracellular or interstitial fluid 
(Peate and Nair 2015). After administration, the fluids are transported to blood or 
lymph capillaries. The transportation of fluids to the circulatory systems occurs via 
diffusion and convection (Richter and Jacobsen 2014).  
When considering the subcutaneous route versus the use of intravenous fluids, it 
should be noted that the subcutaneous route of fluid administration, or 
Hypodermoclysis as it is otherwise known, facilitates slow absorption of the infusion 
(Richter and Jacobsen 2014). Intravenous fluids are given at a much higher rate, and 
in larger quantities.   
The fluids used for subcutaneous infusions are usually licensed for intravenous 
infusion only. The fluids used in subcutaneous infusion must therefore be considered 
as an unlicensed medication, and this should be communicated to the family when 
gaining consent for the treatment to take place. In such cases, the prescriber must 
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take responsibility for any adverse effects resulting from its use. Fluids used for 
subcutaneous infusions include 0.9% Sodium Chloride, which is the usual choice. 
Factors that can affect the area of administration include the concentration of the 
fluid used, and the pH of the solution.  
The site of administration should be one with an adequate amount of subcutaneous 
tissue (Specialist Palliative Care Audit and Guidelines Group (SPAGG) 2017). 
Therefore recommended sites are the abdomen, chest and lateral aspects of the 
upper arm or thigh. Individual assessment of the site areas should be made as the 
child’s physical condition may influence site choice. Site selection can be difficult in 
the end of life phase, as the child may have lost weight, so there is a deficit in the 
available subcutaneous tissue to accommodate an infusion. Rosie’s comfort, 
convenience and safety were also taken into account when assessing the site 
choice. She was not mobile, so the subcutaneous tissue of her thigh was found to be 
most appropriate. During the administration process, subcutaneous tissues swell and 
there is expected to be an indurated area, which will become pink or red. Once the 
infusion is discontinued, the fluid should be absorbed, and the swelling will reduce. In 
Rosie’s case, only a relatively small amount of fluid was required, but generally, it is 
recommended that no more than 2 litres of fluid should be infused at any one 
subcutaneous site.  In line with the procedure described in the Royal Marsden 
Manual of Clinical Nursing Procedures, (Dougherty and Lister 2015), it was 
determined that the infusion site should be rotated every 24-48 hours to decrease 
the likelihood of irritation and to optimize absorption. Rosie was already receiving 
medication for symptom management via the subcutaneous route so care was taken 
to ensure that the fluid infusion site did not interfere with this.  
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Consideration was given to using a syringe driver; however this would not deliver the 
volume of fluid required. A gravity giving set was utilised in this instance (SPAGG 
2017). This requires staff to calculate drip rates and be aware of the observations 
required to ensure that the infusion runs safely.  Observations include continuous 
review of hydration status, and monitoring the child for any infusion or site related 




Complications of subcutaneous fluid administration include; pain, bruising, redness 
and local inflammation. Localised oedema can occur if there is “pooling” of fluids in 
the tissues surrounding the cannula site. Rosie was already being checked hourly, in 
line with the hospice’s procedure for subcutaneous medication administration so the 
site of the subcutaneous fluid cannula was also observed hourly.  
Any increase in fluid volume at the end of life can lead to overload of the circulatory 
system (NICE 2016). This may result in pulmonary oedema, increased respiratory 
secretions and respiratory distress (Keeler 2010), leading to increased anxiety for 
both the child and those providing care. Furthermore, increased urine output may 
distress the child, especially those who are unable to get out of bed and/or access a 
toilet. This may lead to additional medical intervention, such as use of continence 
aids and potentially catheterisation which may be poorly tolerated (NICE 2016). 
A review of fluid requirements was advised after 24 hours by the prescribing clinician 
and a decision to continue the infusion was deemed to be in Rosie’s best interests. 
In total, Rosie received 72 hours of subcutaneous fluids. During the initial stages of 
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the infusion there were no complications.  However when considering further 
infusions it was noted that oedema had developed around the cannula site, posing  
the risk of further irritation and infection. 
Important Considerations 
Discussions about hydration for children receiving end of life care must be held 
sensitively, between the whole team of professionals providing care and the parents 
or carers.  The wishes of the child must also be taken into consideration. Clinical 
staff must ensure that all those involved understand the benefits and risks of giving 
fluids at this time.  Other viable alternatives, such as a nasogastric tube or 
gastrostomy if already in situ, should also be considered. Indications and 
contraindications for subcutaneous fluids are shown in Table 1 below. 
Table 1: Indications and contraindications for subcutaneous fluids  
Indications Contraindications 
Dehydration due to drowsiness due to 
reversible causes (e.g. infection). 
Risk factors for fluid overload and 
existing ascites, heart failure or 
peripheral oedema due to 
hypoalbuminemia 
Inability to swallow Severe renal or hepatic failure 
Unsuitable for gastrostomy, nasogastric 
feeding or other artificial feeding tube 
Severe dehydration, shock or any 
condition requiring the rapid 
administration of fluid 
Symptoms due to dehydration that is not 
responsive to other treatments (e.g. 
thirst, intractable vomiting and / or 
nausea, or severe dry mouth ) 
Major bleeding or coagulation disorders. 
To meet fluid requirements in the short 
term when oral intake is inadequate 
If the patient is imminently dying 
hydration will not improve survival or 
symptom management and may increase 
the risk of distressing respiratory 
secretions. 
Inability to site and maintain intravenous 
fluids 
For medication induced dry mouth 
Strong patient (or carer where the patient 
lacks capacity) informed preference for 
artificial hydration where there are no 
contraindications 
 




Having made a decision to commence subcutaneous fluids, it may be more difficult 
to withdraw this treatment if it is found not to be beneficial (Keeler 2010). Senior 
nursing and medical staff, with experience and skill in communicating difficult 
decisions to parents should be involved at all stages (de Vos et al 2015), particularly 
when treatment is being withdrawn (Larcher et al 2015). 
Support for the team providing care also needs to be considered. There are training 
implications for the knowledge and skills required to administer subcutaneous fluids, 
particularly knowledge of indications and contraindications. The staff caring for the 
child must be an advocate for the child and family, ensuring that any care given is in 
the best interests of the child at all times.  
 
Ethical principles 
The ethical principles of beneficence and non-maleficence are paramount when 
considering a new treatment at the end of a child’s life. Beneficence is the principle 
of doing good and non-maleficence is the principle of doing no harm (Melia 2014). It 
can be difficult to find the perfect balance between these two principles, 
necessitating the consideration of interventions on a case by case basis and 
frequent monitoring and assessment to ensure that the ‘good’ initially achieved does 
not result in consequences which subsequently harm (NICE 2008).  The line 
between both can be very fine and on occasions, although there is some harm this is 
minimal compared to the positives achieved for the child and family.  
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The use of subcutaneous fluids can potentially have adverse consequences, as it 
can be unpleasant, uncomfortable, and at times painful, especially if the child 
experiences an adverse reaction.  It is necessary to balance the benefits and harms 
that the treatment may cause. In considering the treatment to be administered, the 
treatment might involve less harm to the patient than would occur were they not to 
have it. As many treatments involve some pain or discomfort, there has to be an 
assessment of the degree of harm that may be caused. In considering Rosie’s case, 
it was felt the benefits of administration of subcutaneous fluids outweighed the 
potential risks.  The primary consideration was the risk of dehydration. With no other 
means of achieving hydration meaning that Rosie could have been admitted to 
hospital for intravenous fluids, which was not in line with the family’s wishes. Also, by 
providing hydration, it was thought that the painful myoclonus that Rosie was 
experiencing may improve. This proved to be the case.  
 
Conclusion 
This piece presents the case of Rosie, a child nearing the end of her life, who 
received subcutaneous fluids to counteract dehydration and subsequent myoclonus. 
Subcutaneous fluid administration is paediatric palliative care is a relatively 
uncommon practice, and as such there is a paucity of research in this area of care. 
When caring for children at end of life, it is important to ensure that the wishes of the 
child and family are met as much as it is practically possible to do so. The choice of 
place of end of life care, and choice of interventions available can impact on the 
areas able to accommodate the child (NICE 2016).  
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In considering the use of subcutaneous fluids, clinicians must be aware of the 
relative risks and benefits to the child, and how this will impact on the family as a 
whole. There must be a team approach to the delivery of care at end of life, and 
education of staff members in the practical and ethical issues must be made 
available to ensure best interests of the child are met.  
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